Today's Portrait Highlights

Lanthio Pharma

Lanthio Pharma is focused on discovering and developing lantipeptide drugs for serious diseases. We are working on lanthipeptides as new treatment for fibrosis, stroke, heart failure and multiple sclerosis. To discover and produce drug candidates, we apply our proprietary LanthioPep technology. This technology uses modified Lactococcus bacteria to make constrained peptides, called lanthipeptides. Our lanthipeptides are more disease target selective and more stable in plasma compared to linear wild-type peptides, making them more suitable as drug candidates.

WellBiome

Our mission is to give people insight into their body and increase wellbeing and quality of life with relatively small effort. Today, the price of DNA sequencing is at a level that enables us to offer the benefits of the latest, cutting-edge science to almost everyone. Our analysis and recommendations are based on the DNA of the bacteria in your gut. It takes about 2 weeks from receiving your stool sample for us to complete the analysis and email you your personalized report. Our report is useful for anyone who wants to improve their quality of life, have more energy and increase life expectancy. Gut bacteria have an important role in extracting extra energy from the food we eat and small precisely targeted changes in diet can have a big impact on well-being. This report can also help manage weight.

QPS

Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients Worldwide. QPS is well known as a leading CRO for CNS drug development. The availability of the most predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes turn QPS into the first choice for most research needs. Validated transgenic and non-transgenic in vitro and in vivo models cover most targets of AD, PD, HD and other neurodegenerative diseases.